AMLX
Price
$3.95
Change
-$0.33 (-7.71%)
Updated
Dec 18, 04:58 PM (EDT)
98 days until earnings call
MYNDF
Price
$0.06
Change
-$0.01 (-14.29%)
Updated
Nov 29 closing price
Ad is loading...

AMLX vs MYNDF

Header iconAMLX vs MYNDF Comparison
Open Charts AMLX vs MYNDFBanner chart's image
Amylyx Pharmaceuticals
Price$3.95
Change-$0.33 (-7.71%)
Volume$9.06K
CapitalizationN/A
MYND Life Sciences
Price$0.06
Change-$0.01 (-14.29%)
Volume$700
CapitalizationN/A
AMLX vs MYNDF Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. MYNDF commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and MYNDF is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (AMLX: $4.28 vs. MYNDF: $0.06)
Brand notoriety: AMLX and MYNDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 49% vs. MYNDF: 41%
Market capitalization -- AMLX: $293.38M vs. MYNDF: $3.36M
AMLX [@Biotechnology] is valued at $293.38M. MYNDF’s [@Biotechnology] market capitalization is $3.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 1 FA rating(s) are green whileMYNDF’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 1 green, 4 red.
  • MYNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than MYNDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish.

  • AMLX’s TA Score: 4 bullish, 6 bearish.

Price Growth

AMLX (@Biotechnology) experienced а -5.10% price change this week, while MYNDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.60%. For the same industry, the average monthly price growth was +1.53%, and the average quarterly price growth was +3.09%.

Reported Earning Dates

AMLX is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-3.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($293M) has a higher market cap than MYNDF($3.36M). MYNDF YTD gains are higher at: 82.372 vs. AMLX (-70.924).
AMLXMYNDFAMLX / MYNDF
Capitalization293M3.36M8,723%
EBITDAN/AN/A-
Gain YTD-70.92482.372-86%
P/E Ratio2.81N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
AMLX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with ATRA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+2.39%
ATRA - AMLX
65%
Loosely correlated
-1.52%
SLRX - AMLX
58%
Loosely correlated
-4.06%
GRI - AMLX
57%
Loosely correlated
+1.88%
SCPX - AMLX
43%
Loosely correlated
-1.82%
MYNDF - AMLX
32%
Poorly correlated
N/A
More

MYNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNDF has been loosely correlated with ARDX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNDF jumps, then ARDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNDF
1D Price
Change %
MYNDF100%
N/A
ARDX - MYNDF
33%
Loosely correlated
-13.54%
AMLX - MYNDF
32%
Poorly correlated
+2.39%
RNAC - MYNDF
28%
Poorly correlated
-2.71%
TNYA - MYNDF
24%
Poorly correlated
-51.04%
ICCC - MYNDF
24%
Poorly correlated
+3.41%
More